Geron Corporation (GERN)
NASDAQ·Healthcare·Biotechnology
$1.42
-2.07%
Mkt Cap $930.21M
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$5.89
Range $4.00 – $8.00
Implied Upside
+314.8%
Consensus $5.89 vs current $1.42
NASDAQ·Healthcare·Biotechnology
$1.42
-2.07%
Mkt Cap $930.21M
No recent rating data.
Price Target (11 analysts)
$5.89
Range $4.00 – $8.00
+314.8%
Consensus $5.89 vs current $1.42